| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 04/21/2010 | CN101695509A Application of aweto cultured by artificial fermentation in preparing anti-fatigue and anti-hypoxia health product or drug |
| 04/21/2010 | CN101695500A Application of potassium chloride (KCl) in pharmacy |
| 04/21/2010 | CN101167719B Gallo catechin and gallate microcapsule granule and preparation technique thereof |
| 04/21/2010 | CN100998626B Method for preparing extract of korea thistle leaf |
| 04/20/2010 | US7700314 Method for producing polyol-IFN-β conjugate |
| 04/20/2010 | US7700106 Therapeutic agent for ulcerative colitis |
| 04/15/2010 | WO2010040603A1 Dithiolane compounds; compositions containing them; uses for photoprotecting the skin |
| 04/15/2010 | WO2010017332A3 Radioprotectants targeting thrombospondin-1 and cd47 |
| 04/15/2010 | US20100093870 Herbal medicaments for the treatment of neurocerebrovascular disorders |
| 04/15/2010 | US20100093850 Composition containing metal-acidic amino acid chelate accelerating absorption of metal |
| 04/14/2010 | EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof |
| 04/14/2010 | CN101693866A Antler blood wine and processing method thereof |
| 04/14/2010 | CN101693737A Cornu-like polypeptide with antioxidant activity, separation method and application thereof |
| 04/14/2010 | CN101693715A Coumarins compound, preparation method and application thereof |
| 04/14/2010 | CN101693046A Chinese medicine composition capable of improving anoxia endurance |
| 04/14/2010 | CN101692897A Tobacco toxin decomposing liquid |
| 04/14/2010 | CN101254184B Salviol acid B phosphatide complexes and method of preparing the same |
| 04/14/2010 | CN101234121B Application of purslane amide alkaloid in preparing antioxidant and neuroprotective agent |
| 04/13/2010 | US7696331 parenterally administering a dose of samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and carboplatin or taxoids; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 04/13/2010 | US7695742 Plant extract mixtures and their uses |
| 04/13/2010 | CA2360680C Antioxidant compositions and methods for companion animals |
| 04/08/2010 | WO2010039048A1 Compositions and methods for treatment of radiation exposure |
| 04/08/2010 | WO2010037224A1 Method for preventing and treating cardiovascular diseases with brca1 |
| 04/08/2010 | WO2010037172A1 Antioxidant compounds and methods of their use |
| 04/08/2010 | WO2009153665A3 Inhibitors of the shiga toxins trafficking through the retrograde pathway |
| 04/08/2010 | CA2738799A1 Antioxidant compounds and methods of their use |
| 04/08/2010 | CA2738622A1 Compositions and methods for treatment of radiation exposure |
| 04/07/2010 | EP2172246A2 Methods for Alzheimer's disease treatment and cognitive enhancement |
| 04/07/2010 | EP2172204A1 Methods of treating syndrome X with apliphatic polyamines |
| 04/07/2010 | EP2170090A2 Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products |
| 04/07/2010 | CN101691568A Method of producing edible immobilized active probiotics |
| 04/07/2010 | CN101690798A Chinese herba preparation capable of improving antioxidative activity |
| 04/07/2010 | CN101690777A Formula of polygonatum chewable tablets and preparation method thereof |
| 04/06/2010 | US7691903 Oxidation-sensitive hydrophilic active principle containing composition and use thereof |
| 04/06/2010 | US7691425 Method for manufacturing α-glycosylisoquercitrin, intermediate product and by-product thereof |
| 04/01/2010 | WO2010035806A1 Solid pharmaceutical composition |
| 04/01/2010 | WO2010035076A1 Individual 5-fluorouracile dose optimization in folfiri treatment |
| 04/01/2010 | WO2010034118A1 Nitric oxide releasing amino acid ester compound, composition and method of use |
| 04/01/2010 | WO2010015827A3 Phosphate binding materials and their uses |
| 04/01/2010 | WO2010014870A3 Muscadine compositions with improved anti-oxidant activity |
| 04/01/2010 | US20100081681 Methods and compositions for preventing or treating age-related diseases |
| 04/01/2010 | US20100080782 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/01/2010 | US20100080764 Skin Treatment Systems |
| 04/01/2010 | CA2775370A1 Nitric oxide releasing amino acid ester compound, composition and method of use |
| 04/01/2010 | CA2738755A1 Individual 5-fluorouracile dose optimization in folfiri treatment |
| 04/01/2010 | CA2738147A1 Solid pharmaceutical composition |
| 03/31/2010 | EP2169054A1 Vaccine for swine edema disease |
| 03/31/2010 | EP2167474A1 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases |
| 03/31/2010 | EP2167468A2 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof |
| 03/31/2010 | CN101687825A desferrithiocin polyether analogues |
| 03/31/2010 | CN101683461A Application of a traditional Chinese medicine composition in preparation of medicament for inhibiting oxidation damage |
| 03/31/2010 | CN101683351A Application of phlorizin in preparing hepatic or health-care food |
| 03/31/2010 | CN101683108A Ginger and honeysuckle composite flavor soft ice cream size and preparation method thereof |
| 03/31/2010 | CN101683099A Stone-removing detoxication health tea |
| 03/31/2010 | CN100596299C Dehydrosilibinin diester derivatives, preparation method and use thereof |
| 03/30/2010 | CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 03/25/2010 | WO2010032489A1 Iron chelating agent, method for producing same, method for determining amount of iron ions and method for trapping iron ions |
| 03/25/2010 | WO2009099679A3 Treatment of disease conditions via administration of dna repair enzyme |
| 03/25/2010 | US20100076094 Formulation containing phosphate derivatives of electron transfer agents |
| 03/25/2010 | US20100075938 Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular Block |
| 03/25/2010 | US20100074879 Skin agent for external use and cosmetic agent including ubiquinone derivative or salt thereof and method using the same |
| 03/24/2010 | EP2165712A1 Phenolic extracts of almond peel containing procyanidins, propelargonidins and prodelphinidins, and method for preparation thereof |
| 03/24/2010 | EP1112005B2 Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid |
| 03/24/2010 | CN101679293A Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases |
| 03/24/2010 | CN101679263A fluorinated derivatives of deferiprone |
| 03/24/2010 | CN101675975A Ultra-high biomass two-way super-molecule diversity multi-source traditional Chinese medicine preparation |
| 03/24/2010 | CN101675945A New use of Mesona chinensis polyphenol extract |
| 03/24/2010 | CN100594797C Protein capable of antioxidant activity separated from acaleph and application thereof |
| 03/23/2010 | US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 03/23/2010 | US7682632 Tamper-resistant oral opioid agonist formulations |
| 03/23/2010 | US7682442 Spherical particle of activated carbon |
| 03/23/2010 | CA2607237C The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
| 03/18/2010 | WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 03/18/2010 | WO2010028503A1 Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival |
| 03/18/2010 | US20100068316 Phospholipid complexes of olive fruits or leaves extracts having improved bioavailability |
| 03/18/2010 | CA2734309A1 Preparation and usage of a pharmaceutical composition containing ferulic acid and matrine compounds |
| 03/17/2010 | CN101671679A Resistance-relevant gene and applications of radiation-resistant cocci |
| 03/17/2010 | CN101671637A Method for culturing solid nutrient carrier of intestinal probiotics |
| 03/17/2010 | CN101671619A Preparation method of deer blood wine |
| 03/17/2010 | CN101671268A Preparation method of ethylbisiminomethylguaiacol manganese chloride |
| 03/17/2010 | CN101671248A Long effective curcumin derivative and preparation method thereof |
| 03/17/2010 | CN101670111A Thioctic acid-glucan conjugate, preparation method and usage thereof |
| 03/17/2010 | CN101670086A Chinese medicinal health wine |
| 03/17/2010 | CN101670054A Chinese medicinal material with multiple efficacies |
| 03/17/2010 | CN101670027A Compound fleece-flower root oral liquid, preparation method thereof and quality control method |
| 03/17/2010 | CN101670019A Complex preparation having radiation-resisting and eyesight-protecting functions |
| 03/17/2010 | CN101670010A Method for extracting flavonoid glycoside substance |
| 03/17/2010 | CN101669970A Method for microwave extracting fat-soluble toad venom by using skin of Bufo bufo gargarizans |
| 03/17/2010 | CN101669962A Composite glycyrrhizic acid amino acid injection, and preparation method as well as applications thereof |
| 03/17/2010 | CN101669945A Joint synergy of ferulic acid and matrine alkaloid and medical application thereof |
| 03/16/2010 | US7678834 Substituted 4-aminocyclohexanol compounds |
| 03/16/2010 | US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
| 03/16/2010 | US7678779 Methods for the administration of amifostine and related compounds |
| 03/16/2010 | US7678777 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times |
| 03/12/2010 | CA2639562A1 Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival |
| 03/11/2010 | US20100062090 Pharmaceutical Composition Comprising Metadoxine and Garlic Oil For Preventing and Treating Alcohol-Induced Fatty Liver and Steatohepatitis |
| 03/11/2010 | US20100062040 Water soluble drugs and supplements |
| 03/09/2010 | US7674773 Glycosylated derivative of hypolipemic agents; side effect reduction; therapy for insulin resistance; hyperlipidemia agent; impaired lipid metabolism; lowering cholesterol levels |
| 03/04/2010 | US20100055211 Process for producing refined nutraceutic extracts from artichoke waste and from other plants of the cynara genus |
| 03/04/2010 | CA2767961A1 Method of treating organophosphorous poisoning |